Ana Paula Junqueira‐kipnis - Infectious Diseases

Author Information

Ana Paula Junqueira-Kipnis is a prominent researcher in the field of Infectious Diseases. She is affiliated with the Laboratory of Immunopathology of infectious diseases, Department of Immunology, Institute of Tropical Pathology and Public Health at the Federal University of Goiás, located in Goiania, Brazil. Her work primarily focuses on the immunological aspects of infectious diseases, particularly tuberculosis and its interaction with other diseases such as COVID-19.

Research Contributions

Ana Paula Junqueira-Kipnis has made significant contributions to the understanding of tuberculosis, including the immune response to Mycobacterium tuberculosis and the potential cross-protection provided by BCG vaccination against COVID-19. Her research includes the development of novel vaccine strategies and the exploration of immune pathways, such as the NF-κB pathway and its role in latent tuberculosis infection. She has also investigated the virulence of Mycobacterium bovis and the safety and efficacy of BCG revaccination in healthcare workers.

Aliases

Ana Paula Junqueira-Kipnis is known by several aliases in academic publications, including A. P. Junqueira-Kipnis, Ana P. Junqueira-Kipnis, Ana-paula Junqueira-Kipnis, and Ana Paula Junqueira–Kipnis. These variations may appear in different journals and databases.

Publication and Citation Metrics

Metric	Value
Total Papers	112
H-index	25
Total Citations	2297

Publications:

Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade

DOI: 10.3390/biomedicines10040817

Year: 2022

Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis

DOI: 10.3390/vaccines10020306

Year: 2022

Tuberculosis, BCG Vaccination and COVID-19: Are They Connected?

DOI: 10.2174/1389557522666220104152634

Year: 2022

Mycobacterium bovis PknG R242P Mutation Results in Structural Changes with Enhanced Virulence in the Mouse Model of Infection

DOI: 10.3390/microorganisms10040673

Year: 2022

Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial

DOI: 10.3389/fimmu.2022.841868

Year: 2022

Evaluation of in vitro Activation of Bovine Endometrial and Vaginal Epithelial and Blood Mononuclear Cells to Produce Nitric Oxide in Response to Mycoplasma bovis, Mycoplasma bovigenitalium and Ureaplasma diversum

DOI: 10.2478/acve-2021-0012

Year: 2021

Characterization of Mycobacterium tuberculosis var. africanum isolated from a patient with pulmonary tuberculosis in Brazil.

DOI: 10.1016/j.meegid.2020.104550

Year: 2020

Live Vaccines Have Different NK Cells and Neutrophils Requirements for the Development of a Protective Immune Response Against Tuberculosis

DOI: 10.3389/fimmu.2020.00741

Year: 2020

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

DOI: 10.1186/s13063-020-04822-0

Year: 2020

Correction to: BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial

DOI: 10.1186/s13063-020-04913-y

Year: 2020

What Research is Being Done on Dengue Hemorrhagic Fever?

What Measures are Taken to Control Outbreaks?

How often should you wash your hands?

What are the Modes of Transmission?

Are Vaccines Safe?

What are B Cells?

What is Microcephaly?

How is Strep Throat Transmitted?

Can Condoms Be Used for All Types of Sexual Activities?

Why are Throat Swabs Important in Infectious Diseases?

Partnered Content Networks

Relevant Topics